Comment from Matthes Amber
AnonymousSupportIndividual
Summary: The commenter supports the creation of a safe, regulated pathway for compounded peptides to ensure patient and physician access to these treatments. They argue that restricting access could drive patients toward unregulated markets and increase costs for those with chronic conditions.
I am writing to support patient and physician access to safe, regulated compounded peptides.
Compounded peptides, prepared by accredited pharmacies under state and federal oversight, give physicians and pharmacists important tools to care for their patients. Restricting access pushes patients toward an unregulated market and raises costs, which disproportionately affects people managing chronic conditions.
I urge the committee to support a safe, quality, and regulated pathway for these peptides so that the patient-provider relationship is preserved and care stays in accountable channels.
Thank you for considering my comment.